Researchers say the results are encouraging but also shared cautions. More than half of children in early stages of an ongoing study were able to eat a food they were allergic to one year after ...

n = number of patients included in each study group for safety and tolerability assessments Abbreviations: EOS: End of Study (week 16); BID: twice daily; CBD: cannabidiol; QD: once daily. Of the DHT ...

LEWES, Del., Oct. 1, 2025 /PRNewswire/ -- Neteera Technologies Ltd. today announced results from a clinical study demonstrating that its contactless monitoring system achieved 77% sensitivity in ...

n = number of patients included in each study group for HbA1c and body weight efficacy assessments Abbreviations: EOS: End of Study (week 16); Wk: week; BID: twice daily; CBD: cannabidiol; QD: once ...

Stallergenes Greer, a global leader in allergy therapeutics, announced today that its Phase IIIb clinical study (YOBI, YOung patients and BIrch allergy), designed to confirm the safety and efficacy of ...

DehydraTECH-semaglutide reduced overall side effects by 48% as compared to Rybelsus ® DehydraTECH-semaglutide reduced gastrointestinal side effects by 55% as compared to Rybelsus ® Recent financings ...

A study published in the peer-reviewed Equine Veterinary Journal provides hopeful news for owners of show jumpers who have undergone colic surgery. Researchers in Italy noticed that most research in ...